DSC_6710
Tuesday, June 2, 2026
29.9
C
Bengaluru
Hot topics
Astra Zeneca Tops Indian Pharma in New Introductions 2024
Analysis of Indian Pharmaceutical Market (IPM) – 2024
This data...
Interview with Salil Kallianpur
MedicinMan announces workshops on Digital Marketing in Pharma and Sales Force Excellence.
The 500 Billion Dollar Pill: Why Skipping Medicine Is Costing India a Fortune
In the pharmaceutical world, we often focus on the...
India’s Booming OTC Pain Management Market: Trends, Growth & Consumer Behaviors
India’s Booming Pain Management Market: Trends, Growth & Consumer...
Inspirational Frontline Leadership
The last issue of 2016, with articles from K. Hariram and Vivek Hattangadi and new authors, Dr. Ashwin Bonde and Diksha Fouzdar. Diksha's article is the highlight of this issue - an in-depth look at how to embed compliance in the very DNA of a pharma company.
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Hot topics
Astra Zeneca Tops Indian Pharma in New Introductions 2024
Analysis of Indian Pharmaceutical Market (IPM) – 2024
This data...
Creador Bets Big on Indian Pharma with 7% La Renon Stake
In a significant development for the Indian pharmaceutical industry,...
ZS Bets Big on India as Pharma GCCs Rewrite the Global Life Sciences Playbook
With its latest expansion, ZS is placing a decisive...
City Lungs Under Siege: Pigeon Droppings and Interstitial Lung Disease
Feeding pigeons may feel harmless — but for many...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Newsletter
Get important news delivered directly to your inbox and stay connected!